baber/WOPTO huggingface dataset:
Patent CA-2667107-A1 (CA)
Title: Systeme informatique ameliore comprenant plusieurs noeuds en reseau
Inventor: GUITTENIT CHRISTOPHE
IPC: G06F12/08
Filed: 2007-10-25
Abstract: Un système informatique comprend plusieurs postes informatiques dits noeu ds interconnectés en un réseau, des nAEuds stockants comprennent une unité d e mémoire locale (38) à accès direct, et un serveur de stockage (46) pour gé rer l'accès à cette unité sur la base d'une file d'attente, des nAEuds appli catifs, comprennent chacun : un environnement d'application avec une représe ntation de fichiers accessibles sous forme d'adresses de blocs désignant une adresse physique sur une unité de mémoire locale (33), et un client de stoc kage (44) capable d'interagir avec un serveur de stockage (46), sur la base d'une requête d'accès désignant une adresse de blocs. Un serveur de stockage (46) comporte un ordonnanceur capable d'exécuter les requêtes d'accès conte nues dans sa file d'attente (64) dans un ordre déterminé. Cet ordre est déte rminé en fonction d'un jeu de règles formant critères de performance, et imp liquant un ou plusieurs paramètres d'état de la file d'attente et/ou du nAEu d stockant sur lequel il réside.
Patent CA-2667252-A1 (CA)
Title: Sensor for automatic door system, and automatic door system with such sensor used therein
Inventor: KAKUYAMA KOJI
IPC: E05F15/20
Filed: 2007-09-25
Abstract: A light-emitter (26) emits light into a door opening (6) of an automatic door system.                                                              A light-receiver (28) receives light from the light-emitter (26) which has passed through the door opening (6) and develops a light-reception indicative signal.                                                              A door controller (32) causes the light-emitter (26) to stop emitting light and, thereafter, start emitting light.                               An auxiliary sensor (24) is judged to be operating in order when the light-receiver (28) does not develop light-reception indicative signal in a state where the light-emitter (26) is not emitting light, and, thereafter, develops a light-reception indicative signal when the light-emitter (26) resumes emitting light; otherwise, the auxiliary sensor (24) is judged to be out of order.
Patent CA-2668198-A1 (CA)
Title: Solid state lighting compositions and systems
Inventor: NAMBOOTHIRY MANOJ A G
IPC: C09K11/08
Filed: 2007-11-01
Abstract: The present invention relates to lighting technologies and, in particular, to solid state lighting technologies. In one embodiment, the present invention provides a lighting apparatus comprising a first electrode, a radiation transmissive second electrode, and a composite layer disposed between the first and second electrode, the composite layer comprising at least one electric field concentrator and at least one phosphor disposed in a radiation transmissive dielectric material.
Patent CA-2668290-A1 (CA)
Title: Mullion base plate extension
Inventor: MAMCHYCH VICTOR
IPC: E06B5/00
Filed: 2009-05-19
Abstract: This invention relates to a base plate extension for a fire rated mullion that will firmly secure the base of the mullion in the event of a fire; to a low profile base plate;  and, to a mullion assembly comprising a low profile base plate, a mullion latch, and a removable mullion in combination with a double door frame. A removable fire rated mullion is used in conjunction with double door openings to provide a securing point for rim panic bars mounted on doors. For a fire rating to be recognized it must comply with the standard, national Fire Protection Association Inc.  (NFPA) 252 Fire Code. The (NFPA) 252 Fire Code was approved by the American National Standards Institute in 1995.
Patent CA-2670773-A1 (CA)
Inventor: YARGER JAMES
IPC: A61K31/56
Filed: 2007-11-29
Abstract: A compound having the structure : wherein R1, R2, R3, R4, R5, R6, R7 and R9 are independently hydrogen, C1 to C6 alkyl or substituted alkyl, halogen, sulfate or glucuronide moieties; the ---- symbol represents either a single or a double bond and when the ---- symbol is a double bond and forms a keto group at position 3 or 17, then no R7 or R6 is present, respectively; the symbol --- represent the presence or absence of a bond at position 10; and the .sim..sim..sim. symbol represents any type of bond regardless of the stereochemistry. The invention also embraces the enantiomers, other stereochemical isomers, hydrates, solvates, tautomers and pharmaceutically acceptable salts of said compounds.
Patent CA-2671053-A1 (CA)
Title: A tray for collecting and/or treating decomposition fluids from a corpse
Inventor: SPIERS DAVID
IPC: A61L11/00
Filed: 2009-07-02
Abstract: A tray comprising a hollow body for placement within or beneath a coffin for collecting and/or treating decomposition fluids from a corpse within said hollow body, wherein said tray comprises an upper wall and a lower wall defining at least one closed chamber therebetween, said upper wall being provided with at least one drainage aperture in an upper surface through which fluid collected on said outer surface of the upper wall can pass into said at least one closed chamber to be retained and/or treated therein.
Patent CA-2672023-A1 (CA)
Title: Process for the preparation of valsartan and intermediate products
Inventor: FRANTISEK JAROSLAV
IPC: C07D257/04
Filed: 2007-12-11
Abstract: The present invention relates to a new method for the production of valsartan, a valine derivative having the chemical name is (S)-N-(1 -carboxy-2-methylprop-1 -yl)-N-pentanoyl-N- [2'-(1 H-tetrazol-5-yl)-biphenyl-4-ylmethyl]amine, and pharmacologically acceptable salts thereof. Furthermore the invention relates to new intermediate compounds which are suitable for the production of valsartan and new methods for the production of intermediate compounds which are suitable for the production of valsartan.
Patent CA-2674354-A1 (CA)
Inventor: CHABENNE JOSEPH
IPC: C07K14/605
Filed: 2008-01-03
Abstract: Modified glucagon peptides are disclosed having improved solubility while retaining glucagon agonist activity. The glycogen peptides have been modified by substitution of native amino acids with, and/or addition of, charged amino acids to the carboxy terminus of the peptide. The modified glucagon agonists can be further modified by pegylation, or the addition of a carboxy terminal peptide selected from the group consisting of SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 23, or both to further enhance the solubility of the glucagon agonist analogs.
Patent CA-2674916-A1 (CA)
Inventor: NAGARAJ THADI M
IPC: H04N21/2385
Filed: 2008-01-30
Abstract: In general, this disclosure describes techniques for exchanging information between a plurality of encoder modules and a multiplex module to combine segments of data from the encoder modules with an improved overall quality. In particular, the encoder modules associate their respective segments of data with quality and rate information and send at least the quality and rate information associated with the segments of data to the multiplex module. The multiplex module analyzes the quality and rate information to determine whether the segments of data that encoder modules desire to include in the current superframe fit within the available bandwidth of a transmission channel. If the multiplex module determines the plurality of segments of data do not fit within the available bandwidth, the multiplex module selects one or more of the segments to be resized based on the quality and rate information received from the encoder modules.
Patent CA-2676017-A1 (CA)
Title: Zinc-based screening test and kit for early diagnosis of prostate cancer
Inventor: FREDERICKSON CHRISTOPHER J
IPC: G01N33/487
Filed: 2008-01-25
Abstract: The present invention provides devices, kits, and methods for determining the zinc level in a fluid sample of a subject. Such determination is useful in screening for the presence of or the increased risk of having prostate cancer.
Patent CA-2676489-A1 (CA)
Title: Haemostat application
Inventor: HARDY CRAIG JULIAN
IPC: A61B17/00
Filed: 2008-01-25
Abstract: A tool for application of a haemostat to a site of bleeding comprises a cylindrical barrel (10), a plunger (11) slidable in the barrel, the barrel (10) having an outlet end (18). The outlet end (18) may be configured as a cone or rounded end with a central aperture (19) and longitudinal slots (20) in a cruciform arrangement, or may be left open. The barrel may have a slot (39) alignable with a slot (37) in an inner member for insertion of a haemostat body (40) in the barrel. The barrel and plunger may be separable for insertion of the body into an open end of the barrel.
Patent CA-2677193-A1 (CA)
Inventor: FUKUTA MAKOTO
IPC: A61K9/16
Filed: 2008-01-30
Abstract: The present invention provides a tablet without causing a tableting trouble, which is superior in the tablet formability, dissolution property of pharmaceutically active ingredient, and the like.
Patent CA-2680311-A1 (CA)
Title: Enhanced whois query mechanism
Inventor: BOWDEN TREVOR SCOTT
IPC: H04L12/16
Filed: 2009-09-23
Abstract: A system for providing certification credentials to companies for use on a website makes use of a centralized database such as the WHOIS database. A logo associated with the credential is used to provide consumers with a link to the stored information that serves as the basis for the issuance of the credential, and the right to display the logo.
Patent CA-2681752-A1 (CA)
Inventor: GOTTSCHALK STEFAN
IPC: A61P37/02
Filed: 2008-03-27
Abstract: The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.
Patent CA-2681832-A1 (CA)
Title: Blowing agent composition of hydrochlorofluoroolefin
Inventor: COSTA JOSEPH S
IPC: C08J9/00
Filed: 2008-03-28
Abstract: A blowing agent for thermosetting foams is disclosed. The blowing agent is predominately the trans isomer of the hydrochlorofluoroolefin (HCFO) HFCO-1233zd alone or in combination with a hydrofluoroolefin (HFO), hydrofluorocarbon (HFC), hydrochlorofluoroolefin (HCFO), a hydrocarbon. The blowing agent is effective as a blowing agent in the manufacture of thermosetting foams.
Patent CA-2683521-A1 (CA)
Title: Method and apparatus to mechanically reduce food products into irregular shapes and sizes
Inventor: SAMMEL LAUREN MICHELE
IPC: A22C17/00
Filed: 2009-10-27
Abstract: Methods and apparatus are disclosed for producing irregular slices of meat from meat products. The meat products can be rotated using an impeller having a plurality of paddles for urging the meat products against a slicing blade during rotation of the impeller in order to create a slice from the meat product. The meat products can impact the slicing blade in different orientations in order to create differently shaped, irregular slices of meat. A cutting blade downstream of the slicing blade can be used to reduce the width of the slices of meat.
Patent CA-2683741-A1 (CA)
Title: Acides polyglutamiques fonctionnalises par des groupements cationiques et des groupements hydrophobes et leurs applications, notamment therapeutiques
Inventor: BONNET GONNET CECILE
IPC: C08G69/48
Filed: 2008-05-05
Abstract: La présente invention concerne des nouveaux matériaux à base de polyamino acides modifiés, biodégradables, utiles notamment pour la vectorisation de p rincipe(s) actif(s) (PA). L'invention vise aussi de nouvelles compositions p harmaceutiques, cosmétiques, diététiques ou phytosanitaires à base de ces po lyaminoacides. Le but de l'invention est de fournir une nouvelle matière pre mière polymère, susceptible d'être utilisée pour la vectorisation de PA et p ermettant de satisfaire de manière optimale à toutes les spécifications requ ises en l'espèce : biocompatibilité, biodégradabilité, aptitude à s'associer facilement avec de nombreux principes actifs ou à les solubiliser, et à lib érer ces principes actifs in vivo. Ce but est atteint par la présente invent ion qui concerne des nouveaux polyglutamates modifiés par des groupements ca tioniques qui, s'ils sont déprotonables, présentent un pKa supérieur ou égal à 7, et par des groupements hydrophobes comportant de 8 à 30 atomes de carb one. Ces polyglutamates modifiés par des groupements cationiques sont aptes à se transformer aisément et économiquement en particules de vectorisation d e principes actifs, ces particules étant elles-mêmes propres à former des su spensions colloïdales aqueuses stables. Ces polyglutamates modifiés présente nt l'avantage d'être moins visqueux que d'autres polymères analogues, tout e n conservant une capacité à associer des protéines telles que l'insuline. Ce rtains sont solubles dans l'eau à pH acide et deviennent insoluble à pH phys iologique (7,4) et devraient donc, lors d'une injection sous-cutanée, précip iter sur le site d'injection.
Patent CA-2684194-A1 (CA)
Inventor: NOEL JOHN RICHARD
IPC: A61F13/20
Filed: 2008-04-15
Abstract: A tampon having at least one physical discontinuity is provided. The physical discontinuity, or physical discontinuities, are located in the compressed absorbent member and may be made in the tampon pledget before the pledget is compressed into the absorbent member. The physical discontinuities partially isolate a portion, or portions, of the tampon from the rest of the tampon. The partial isolation of a portion of the tampon reduces the amount of menses absorbed by that portion, which could be transported to the rest of the tampon through wicking. The concentration of menses absorption in a portion allows that portion have a higher level of expansion than the rest of the tampon to prevent menses from leaking out of the vaginal opening.
Patent CA-2687988-A1 (CA)
Inventor: BORSCHERT BERNHARD WALTER
IPC: B23B51/00
Filed: 2008-04-19
Abstract: The drilling tool (4, 28) functions particularly as a special drill for dry drilling or for drilling special materials such as stainless steel. The drilling tool (4, 28) has a drilling head (2) with two primary cutting edges (22A, 22B) which are separated from each other by a cutting height difference (.DELTA.h). A drilling point (18) is also arranged displaced from a middle axis (16) such that one of the two primary cutting edges (22A) has a larger radial length. By these means, the drilling tool (4, 28) drills a larger bore hole (26) than the drill bit nominal diameter (D1). In addition, the cutting height difference (.DELTA.h) produces a radial force component (FB) working in the opposite direction such that the radial load on the drilling tool (4, 28) is reduced.
Patent CA-2691220-A1 (CA)
Inventor: YOSHIKAWA SATORU
IPC: C07D489/08
Filed: 2008-06-20
Abstract: The present invention aims to provide a therapeutic or prophylactic agent for schizophrenia, which therapeutic or prophylactic agent can treat especially positive symptoms of schizophrenia and does not cause impaired information processing related to cognitive deficiencies or the like which is a symptom of schizophrenia.  That is, a therapeutic or prophylactic agent for schizophrenia, comprising as an effective ingredient a compound having a specific morphinan skeleton represented by the compound 1 below or a pharmaceutically acceptable acid addition salt thereof, was provided.
Patent CA-2691604-A1 (CA)
Inventor: SCHMITTHAEUSLER ROLAND
IPC: C07K1/18
Filed: 2008-07-04
Abstract: L'invention consiste en une utilisation d'un support de chromatographie d 'échanges d'ions comprenant une résine de type polymère vinylique à larges p ores portant des groupements DEAE et d'un tampon comprenant du citrate triso dique, du chlorure de sodium, du chlorure de calcium, de la glycine et de la lysine pour réduire la quantité d'ADAMTS13 présente dans une solution dériv ée du plasma contenant du facteur von Willebrand humain.
Patent CA-2692572-A1 (CA)
Inventor: OLD DAVID W
IPC: A61P27/06
Filed: 2008-06-30
Abstract: Disclosed herein are compounds having formula (I) wherein a dashed line represents the presence or absence of a bond; Y is an organic acid functional group, or an amide or ester thereof;  or Y is hydroxymethyl or an ether thereof; or Y is a tetrazolyl functional group; A is -(CH2)6-, cis -CH2CH=CH-(CH2)3-, or -CH2C=C-(CH2)3-, wherein 1 or 2 carbon atoms may be replaced by S or O; or A is -(CH2)m-Ar-(CH2)o- wherein Ar is interarylene or heterointerarylene, the sum of m and o is 1, 2, 3, or 4, and wherein 1 -CH2- may be replaced by S or O, and 1-CH2-CH2- may be replaced by -CH=CH- or -C.ident.C-; U1 and U2 are independently selected from -H, =O, -OH, -F, -Cl, and -CN; and B is aryl or heteroaryl, for use as acular hypotensive agent.
Patent CA-2693690-A1 (CA)
Title: Alkylaromatics production
Inventor: CLARK MICHAEL C
IPC: C07C2/66
Filed: 2008-06-05
Abstract: A process is described for producing an alkylaromatic compound, in which a first feed comprising an alkylatable aromatic compound and a second feed comprising an alkene are introduced into a first alkylation reaction zone comprising a first alkylation catalyst. The first alkylation reaction zone is operated under conditions effective to cause alkylation of the alkylatable aromatic compound by the alkene to produce said alkylaromatic compound, the conditions being such that the alkylatable aromatic compound is at least predominantly in the vapor phase. A first effluent comprising the alkylaromatic compound and unreacted alkylatable aromatic compound is withdrawn from the first alkylation reaction zone and at least part of the unreacted alkylatable aromatic compound is treated to remove catalyst poisons therefrom and produce a treated unreacted alkylatable aromatic stream. At least part of the unreacted alkylatable aromatic compound and a third feed comprising said alkene is introduced into a second alkylation reaction zone comprising a second alkylation catalyst. The second alkylation reaction zone is operated under conditions effective to cause alkylation of the unreacted alkylatable aromatic compound by the alkene to produce said alkylaromatic compound, the conditions being such that the alkylatable aromatic compound is at least predominantly in the liquid phase. A second effluent comprising said alkylaromatic compound is withdrawn from the second alkylation reaction zone.
Patent CA-2694045-A1 (CA)
Inventor: HARDING IAN
IPC: G01N33/53
Filed: 2008-07-24
Abstract: A method and apparatus for electrochemical detection of analyte in a sample makes use of a binding interaction and relies on the discovery that asymmetric distribution of a redox enzyme between two electrodes that occurs when a redox enzyme-containing reagent is immobilized at the surface of one electrode can be detected as a chemical potential gradient arising from an asymmetry in the distribution of oxidized or reduced redox substrate. This chemical potential gradient can be detected potentiometrically by observing the potential difference between the electrodes in an open circuit, or amperometrically by observing the current flow between the electrodes when the circuit is closed. In both cases, the observation of asymmetry can be done without the application of an external potential or current to the electrodes.
Patent CA-2695321-A1 (CA)
Inventor: ANDROUTSELLIS-THEOTOKIS ANDREAS
IPC: C12N5/0797
Filed: 2008-08-14
Abstract: Methods are disclosed herein for increasing the number of stem cells or precursor cells. The number of stem cells can be increased by increasing survival and/or cell proliferation of the cells. The methods include contacting the cells with an effective amount of a Notch ligand, an effective amount of a growth factor, and an effective amount of angiopoietin-2 (Ang-2). In several embodiments, the methods include contacting the cells with an effective amount of a Jak inhibitor. In several non-limiting examples, the growth factor is insulin or glial derived neurotrophic factor (GDNF), or a combination thereof. In additional non-limiting examples, the Notch ligand is Delta. The cells can be in vivo orin vitro. Methods are also disclosed here for the treatment of a neurodegenerative disorder or spinal cord injury in a subject. In several non-limiting examples, the subject has Parkinson's disease or Alzheimer's disease.
Patent CA-2700152-A1 (CA)
Inventor: EDGE STEPHEN W
IPC: H04N21/454
Filed: 2008-10-03
Abstract: L'invention concerne des techniques d'envoi et de réception d'informations de diffusion. Dans un aspect de l'invention, des métadonnées de diffusion peuvent être générées pour des informations de diffusion et peuvent comprendre des critères positionnels et temporels utilisés par des terminaux pour filtrer les informations de diffusion. Chaque critère positionnel et temporel peut comprendre (i) un critère positionnel donné par une position cible et une condition de présence ou d'absence et (ii) un critère temporel donné par une période temporelle pendant laquelle le critère positionnel s'applique. Un terminal peut recevoir les métadonnées de diffusion avant ou en même temps que les informations de diffusion, obtenir des critères positionnels et temporels à partir des métadonnées de diffusion, et filtrer les informations de diffusion en fonction des critères positionnels et temporels. Le terminal peut évaluer chaque critère positionnel et temporel en déterminant sa position pendant une période de temps spécifique et en déterminant si sa position est située à l'intérieur ou à l'extérieur d'une position cible spécifiée, telle qu'indiquée par la condition de présence ou d'absence.
Patent CA-2701705-A1 (CA)
Title: Trimeric il-1ra
Inventor: HOLTET THOR LAS
IPC: C07K14/47
Filed: 2008-10-08
Abstract: Interleuekin-1 receptor antagonists (IL-1Ra) including fusion proteins having a trimerizing domain and an IL-1Ra polypeptide sequence. The fusion proteins are part of trimeric complexes that are used in pharmaceutical compositions for treating diseases mediated by IL-1. Effective treatment of inflammatory diseases, such as rheumatoid arthritis and diabetes, are described.
Patent CA-2703345-A1 (CA)
Inventor: LEVIT ERAN
IPC: A61F2/958
Filed: 2008-10-22
Abstract: A balloon catheter system for the intraluminal advancement of conventional guidewires beyond partially or fully occluded or stenosed lesions in body passages, such as CTOs in the vasculature, is provided. Balloons are provided. In certain embodiments of the invention, a balloon having relatively thickened proximal tapers is provided. In certain embodiments of the invention, balloons having a tapered midsection are provided. The balloons are preferably useful with crossing balloon catheter systems. In certain embodiments of the invention, the balloons preferably reduce or minimize trauma to the vascular wall or wall of other body passage in which it is used.
Patent CA-2703498-A1 (CA)
Inventor: STOLL RENE
IPC: G01C23/00
Filed: 2008-10-31
Abstract: A display module for displaying passenger-specific display information in an aircraft, said module comprising: a display unit, a controller, a memory, and a first interface, said first interface being connected to said controller, and said controller being designed to read out memory content that is stored in the memory and associated with the signal regarding the display information, on the basis of a signal applied to the first interface, and to activate the display unit on the basis of the memory content which is read out and the signal which is applied to the interface.
Patent CA-2707084-A1 (CA)
Inventor: PRENCIPE MICHAEL
IPC: A61K8/44
Filed: 2008-03-28
Abstract: This invention relates to oral care compositions comprising an effective amount of a basic ammo acid in free or salt form, together with an anionic surfactant, and to methods of using and of making such compositions